Where Your Money Goes
JDRF is dedicated to pursuing the most promising paths to cure, better treat, and prevent type 1 diabetes.
We bring together research, business, governments and members of the type 1 diabetes community to increase the overall volume and impact of research conducted around the world.
Scientists here in Australia attract the highest per capita allocation of competitive research investment by JDRF internationally, and this is a direct reflection of the value of our local diabetes researchers.
The researchers, scientists and clinicians working in the field of type 1 diabetes are exceptional, and with enough funding and resources they hold the key to a cure.
|Research Funded Globally in FY2010||US$107 million|
|Research funded or supported in Australia in 2009/10||AUD$9.8 million|
|Global Research Funding broken down by therapeutic area (all figures in US dollars)|
|Beta Cell Therapies||$35 million|
|Immune Therapies||$32 million|
|Total Cure Therapies Funding Globally (2009/10)||$67 million|
|Complications Therapies||$17 million|
|Glucose Control||$23 million|
|Total Treatment Therapies Funding Globally (2009/10)||$40 million|
|Percentage of JDRF expenditures that directly support research and research-related education:||more than 80%|
|Cumulative research funding since 1970||US$1.5 billion|
|Number of countries in which JDRF funds research||19|
|Number of clinical trials currently funded||40+|
|FY11 research funding goal (projected)||US$124 million|